Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

At Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw, clinical research in respiratory tract diseases focuses on serious lung conditions such as idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease. These studies are designed to evaluate new treatment options and better understand their impact on lung function and symptom control.

• Testing potential therapies for progressive lung fibrosis and related breathing problems
• Studying treatment effects in systemic sclerosis with lung involvement
• Assessing whether new approaches can slow decline in lung function

This area reflects a strong interest in improving care for patients with chronic and often hard-to-treat pulmonary disease.

The site also carries out extensive research in neoplasms, including acute myeloid leukemia, myelodysplastic syndrome, breast cancer, advanced non-small cell lung cancer, and head and neck cancer. These trials are mainly aimed at testing new cancer therapies, improving response rates, and understanding how treatments work in difficult-to-treat disease settings.

• Evaluating novel treatment combinations for advanced solid tumors and blood cancers
• Studying treatment effectiveness in acute myeloid leukemia and high-risk myelodysplastic syndrome
• Exploring new immunotherapy strategies for lung cancer and head and neck cancer

This oncology portfolio shows active work on both early treatment response and longer-term disease control.

In cardiovascular diseases, the research includes coronary artery disease, heart failure, and prevention of ischemic stroke after recent cerebrovascular events. These trials are focused on improving diagnosis, reducing complications, and testing therapies that may lower the risk of major cardiovascular outcomes.

• Evaluating new options for patients with heart failure with preserved or mildly reduced ejection fraction
• Studying stroke prevention after transient ischemic attack or acute ischemic stroke
• Assessing diagnostic tools for suspected coronary artery disease

The cardiovascular program combines treatment and diagnostic research to support earlier and more effective care.

Clinical trials in immune system diseases at this institution cover giant cell arteritis, systemic lupus erythematosus, systemic sclerosis, and ulcerative colitis. The main purpose is to compare new therapies with established treatments and to improve control of inflammation, symptoms, and disease activity.

• Comparing treatments for giant cell arteritis to achieve sustained remission
• Testing therapies for systemic lupus erythematosus and systemic sclerosis
• Studying new approaches for ulcerative colitis in patients with active disease

This research supports broader efforts to find safer and more effective long-term management strategies for autoimmune conditions.

The site’s trial portfolio also includes musculoskeletal diseases, nervous system diseases, and female urogenital diseases. Research in these areas addresses endometriosis-related pain, multiple sclerosis, and other conditions where better symptom relief, disease control, or treatment tolerance is needed.

• Evaluating new options for endometriosis and pelvic pain relief
• Studying treatment alternatives for multiple sclerosis
• Exploring therapies that may improve quality of life in chronic inflammatory disorders

These studies broaden the research focus beyond major internal medicine specialties and into conditions that strongly affect daily functioning.